Apodemus AB is a Swedish pharmaceutical company focused on the development of antiviral treatments and diagnostic tools for viral infections.
We work according to the hypothesis that “Enterovirus is the common environmental factor that underlie a wide range of diseases and that these diseases can be treated by antiviral therapy”.
Apodemus is non-public, privately owned, small pharmaceutical company. We are focused on the development of novel antiviral treatments targeting enteroviruses.
Apodemus fulfills the SME (small and medium size enterprise) criteria and has granted SME status by the European Medicines Agency (EMA).